New England Biolabs is focused on the discovery and development of recombinant and native enzymes for genomic research. It offers restriction endonucleases for DNA digestion; PCR, polymerases, and amplification technologies for PCR applications; DNA modifying enzymes and cloning technologies; reagents for DNA and RNA sample preparation; DNA, RNA, and protein markers and ladders for electrophoresis applications; reagents for RNA research; and gene expression tools for DNA, RNA, and protein transfection of cell lines. The company also offers cellular analysis solutions; reagents, enzymes, antibodies, and DNA controls for epigenetics research; protein expression and purification technologies; competent cells for transformation and protein expression; protein tools; glycobiology products; and plasmids and DNAs for use in cloning experiments. New England Biolabs was founded in 1974 and is based in Ipswich, Massachusetts.

ICOS Corporation is a biotechnology company that engages in the discovery, development, and commercialization of therapeutic products. It is engaged in the commercialization of treatments for unmet medical conditions, such as benign prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. It is the developer of a treatment known as Cialis (tadalafil), a product for the treatment of erectile dysfunction through its joint venture with Eli Lilly and Company in North America and Europe. It is also engaged in contract manufacturing services for third parties. It is in a strategic alliance with Solvay Pharmaceuticals, Inc. ICOS Corporation was established in 1989, based in Bothell, Washington. It is currently operated by Eli Lilly and Company.

IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions. IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.

Mycogen LLC manufactures and sells agricultural products. The company was founded by Andrew C. Barnes and David H. Rammler in 1982 and is headquartered in Indianapolis, IN.

Syngenta AG is a global company that produces agrochemicals and seeds and is based in Basel, Switzerland. As a biotechnology company, it conducts genomic research. It was formed in 2000 by the merger of Novartis Agribusiness and Zeneca Agrochemicals. As of 2014 Syngenta is the world’s largest crop chemical producer As of 2009 it ranked third in seeds and biotechnology sales. Sales in 2015 were approximately US$13.4 billion, over half of which were in emerging markets. It is owned by ChemChina, a Chinese state-owned enterprise.

Zeneca is a British multinational pharmaceutical company focused on therapeutic oncology and cardiovascular products. Zeneca was established in June 1993 through a demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries. In 1999 Zeneca and Astra AB, a Sweden-based pharmaceutical company, merged to form AstraZeneca plc.

Zhuhai Yupintang Biotechnology Co., Ltd., established on 2006-01-23, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:food business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are approved by relevant departments,documents or permits shall prevail)

Board of Trustees of Michigan State University, part of Michigan State University, is an American company that trusts Except Educational Religious.

Innovate Calgary is where startups, entrepreneurs, researchers, investors, industry and partners take innovation and ideas to business. It takes an ecosystem to drive the commercialization success of an innovation or discovery, and we are here to give you the help you need to take your startup, discovery or investment to the next stage of growth or market entry. How? It's simple, Just Ask. Innovate Calgary is the technology-transfer and business-incubation centre for the University of Calgary. Working closely with Research Services and the Office of the Vice-President (Research), we work to help bridge the gap between discovery and innovation.

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.

Merrill Lynch Smith Barney (Xiamen) Biotechnology Co., Ltd., established on 2017-01-23, Business scope includes medical research and experimental development;Biotechnology Extension Services;Biopharmaceutical Manufacturing;Other medical equipment and equipment manufacturing;Wholesale of Class III Medical Devices;Retailing of Class III Medical Devices;Wholesale of Class I Medical Devices;Wholesale of Class II Medical Devices;Retailing of Class I Medical Devices;Retailing of Class II Medical Devices;investment management(law,Unless otherwise specified by law);asset Management(law,Unless otherwise specified by law);Other unlisted business management services(Items not subject to approval);Business Management Consulting;Investment Advisory(law,Unless otherwise specified by law);Investment Management Consulting(law,Unless otherwise specified by law);Domestic Freight Forwarding;International Freight Forwarding;Other unspecified transportation agency business(Not subject to permit approval);Other warehousing(Items not subject to permit approval);Mechanical equipment storage service;Other unlisted machinery and equipment leases(Items not subject to permit approval);to the primary industry,Secondary industry,Investment in the tertiary industry(law,Unless otherwise specified by law);Other unlisted professional and technical service industries(Not subject to permit approval);Retailing of cosmetics and hygiene products;Wholesale of other mechanical equipment and electronic products;computer,Retailing of Software and Ancillary Equipment;Wholesale of other chemical products(Free of hazardous and monitored chemicals);Import and export of various commodities and technologies(Import and export commodity catalog is not attached),Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.

Mogen International Nv, a subsidiary of AstraZeneca PLC, is a Dutch company located in Leiden involved in medicinal chemicals and botanical products. On May 01, 1997 Zeneca Group Plc acquired Mogen International Nv for $74.96 million.

Parasight System provides animal health technology solutions for the veterinary and consumer markets. It provides an automated fecal egg count diagnostic and intestinal parasite management tool for veterinarians. This portable veterinarian-based solution provides rapid, quantitative fecal egg counts in animals. Parasight was developed by MEP Equine Solutions, a Lexington, KY based company. MEP Equine Solutions is an animal health technology company that focuses on veterinarian and consumer based solutions.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

A globally renowned manufacturer of Small Volume Parenterals (SVPs), Gland Pharma was founded in 1978 at Hyderabad by a visionary, PVN Raju. Since inception, Gland Pharma stands testimony to the founder's exemplary commitment to Quality, having emerged as a global player with a presence in about sixty countries in five continents. Our major share of business is from the regulated markets like USA, Canada, Europe and Australia. Our expertise includes in-house development and manufacturing of injectable products and we provide contract development and manufacturing services to global partners for high quality injectable products. We have a wide range of injectables, including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, oncology and ophthalmic solutions. We enjoy the distinction of having pioneered Heparin technology in India, and are world leaders in the Glycosaminoglycans (GAGs) range of molecules.